Elutia Execs to Present at Sidoti Small-Cap Conference
Event summary
- Elutia CEO Dr. Randy Mills and CFO Matt Ferguson to present at Sidoti’s Small-Cap Virtual Investor Conference on March 19, 2026, at 2:30 p.m. ET.
- Company will discuss its drug-eluting biomatrix technology for post-surgical infection in implant-based breast reconstruction.
- Elutia will host one-on-one investor meetings on March 18–19, 2026.
- Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, organizes the conference, focusing on small- and microcap companies.
The big picture
Elutia’s participation in the Sidoti conference underscores its focus on engaging small-cap investors as it seeks to address a critical unmet need in implant-based breast reconstruction. The event provides a platform to showcase its technology amid growing demand for safer reconstructive outcomes post-mastectomy. Sidoti’s specialized focus on small- and microcap companies suggests Elutia is targeting a niche investor base familiar with high-risk, high-reward medical technologies.
What we're watching
- Technology Validation
- How Elutia’s presentation will position its drug-eluting biomatrix technology in the competitive landscape of post-surgical infection solutions.
- Investor Sentiment
- Whether the one-on-one meetings will generate renewed interest or skepticism among small-cap investors.
- Regulatory Pathway
- The pace at which Elutia can advance its technology through clinical trials and regulatory approvals.
Related topics